Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.46B | 1.59B | 1.58B | 1.44B | 1.31B | 745.21M |
Gross Profit | 967.42M | 1.15B | 1.14B | 1.04B | 951.08M | 512.74M |
EBITDA | 959.56M | 1.29B | 1.02B | 966.09M | 1.29B | 63.28M |
Net Income | 6.93B | 933.68M | 862.57M | 723.37M | 1.08B | 349.82M |
Balance Sheet | ||||||
Total Assets | 22.74B | 25.51B | 24.74B | 24.67B | 22.74B | 22.42B |
Cash, Cash Equivalents and Short-Term Investments | 365.13M | 156.36M | 140.70M | 248.40M | 365.13M | 183.62M |
Total Debt | 8.19B | 8.97B | 9.50B | 9.61B | 8.19B | 8.73B |
Total Liabilities | 9.05B | 9.79B | 10.34B | 10.39B | 9.05B | 9.35B |
Stockholders Equity | 13.67B | 15.52B | 14.20B | 14.07B | 13.67B | 13.04B |
Cash Flow | ||||||
Free Cash Flow | 808.21M | 865.49M | 961.21M | 896.15M | 733.69M | 323.99M |
Operating Cash Flow | 808.70M | 1.04B | 1.08B | 1.02B | 827.53M | 379.68M |
Investing Cash Flow | -948.59M | -520.57M | -38.88M | -926.02M | 256.40M | -922.41M |
Financing Cash Flow | 23.16M | -507.98M | -1.15B | -214.25M | -902.42M | 524.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | S$15.95B | 16.03 | 6.32% | 4.99% | 1.54% | 4.48% | |
61 Neutral | AU$2.82B | 8.09 | 4.17% | 5.29% | 17.25% | 41.52% | |
$2.63B | 15.34 | 5.22% | 7.67% | ― | ― | ||
$3.61B | 20.72 | 5.08% | 4.01% | ― | ― | ||
$5.21B | 11.94 | 6.29% | 4.77% | ― | ― | ||
$2.17B | 34.72 | 11.74% | 1.24% | ― | ― | ||
$2.60B | 30.76 | 1.86% | 5.45% | ― | ― |
CapitaLand Integrated Commercial Trust has announced the update of its Euro Medium Term Note Programme, increasing the programme limit from US$3 billion to US$7 billion. This update allows the issuance of notes in various currencies and incorporates the option to issue Australian law medium term notes, potentially enhancing CICT’s financial flexibility and market reach.
The most recent analyst rating on (SG:C38U) stock is a Buy with a S$2.45 price target. To see the full list of analyst forecasts on CapitaLand Mall stock, see the SG:C38U Stock Forecast page.
CapitaLand Integrated Commercial Trust has issued 3,044,633 units at S$2.1016 per unit to Premier Healthcare Services International Pte Ltd as part of the payment for the management fee for the first quarter of 2025. This issuance represents 50% of the base component of the management fee, with the remaining 50% to be paid in cash, increasing the total units in issue to over 7.3 billion. This move reflects CICT’s strategy to manage its financial obligations while maintaining its operational efficiency.
The most recent analyst rating on (SG:C38U) stock is a Buy with a S$2.45 price target. To see the full list of analyst forecasts on CapitaLand Mall stock, see the SG:C38U Stock Forecast page.
CapitaLand Integrated Commercial Trust held its Annual General Meeting on April 22, 2025, at Marina Bay Sands Expo and Convention Centre. The meeting was attended by unitholders, proxies, and the board of directors, including key figures such as the Chairman and the CEO. This gathering underscores CICT’s commitment to transparency and stakeholder engagement, essential for maintaining trust and confidence in its operations and strategic direction.
The most recent analyst rating on (SG:C38U) stock is a Buy with a S$2.45 price target. To see the full list of analyst forecasts on CapitaLand Mall stock, see the SG:C38U Stock Forecast page.